Efficacy and Safety of AbobotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Incontinence Performing Regular Clean Intermittent Catheterization: Pooled Results from Two Phase 3 Randomized Studies (CONTENT1 and CONTENT2)
UrologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- European urology
- Publicado em
- 7 abr 2022
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Efficacy and Safety of AbobotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Incontinence Performing Regular Clean Intermittent Catheterization: Pooled Results from Two Phase 3 Randomized Studies (CONTENT1 and CONTENT2)
Michael Kennelly, Francisco Cruz, Sender Herschorn, Paul Abrams, Kadir Onem, Viktor Kibanov Solomonov, Elena Del Rosario Figueroa Coz, Andrei Manu-Marin, Antonella Giannantoni, Catherine Thompson et al.
Descritores MeSH
- Urinary Bladder, Neurogenic
- Urinary Incontinence
- Botulinum Toxins, Type A
- Urinary Bladder, Overactive
- Intermittent Urethral Catheterization
- Neuromuscular Agents
- Humans
- Urodynamics
- Quality of Life
- Treatment Outcome
Veja também
Estudos relacionados
- Efficacy of abobotulinumtoxinA versus onabotulinumtoxinA for the treatment of refractory neurogenic detrusor overactivity: a systematic review and indirect treatment comparison
- Early intradetrusor injection of Onabotulinumtoxin A in patients with subacute spinal cord injury: The SCIBOT study
- Botulinum toxin injections for Japanese patients with urinary incontinence caused by neurogenic detrusor overactivity: Clinical evaluation of onabotulinumtoxinA in a randomized, placebo-controlled, double-blind trial with an open-label extension
- Comparative Effectiveness of Botulinum Toxin a Versus Placebo for Neurogenic Overactive Bladder: A Meta-Analysis